Stocktwits on MSN

IBIO stock soars 12% pre-market after company announces $26 million private placement

Bio intends to use the proceeds from the private placement toward advancing its preclinical cardiometabolic programs. ・This includes the IBIO-610, IBIO-600, and the myostatin and activin A bispecific ...

Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.